Hair loss treatment ingredients, possible treatment for Alzheimer's disease...dramatic improvement in brain function

Mar 18, 2025

Hair loss treatment ingredients, possible treatment for Alzheimer's disease...dramatic improvement in brain function
Rosemary Photography Source=Pixabay



A study has found that hair loss treatment ingredients can be used as a preventive and treatment for Alzheimer's disease.

A joint research team from the Scripps Research Institute of the United States and the Medical School of California recently published a research paper on the efficacy of carnosan, an antioxidant and anti-inflammatory compound, in the international journal 『Antioxidants』.

Carnosan is an ingredient contained in rosemary and sage, a type of herb plant, and is also used to promote hair growth.




The researchers found that when mice with Alzheimer's disease were given carnosic acid for three months, brain function was dramatically improved.

In particular, memory has been restored and brain inflammation, one of the causes of Alzheimer's disease, has been shown to be significantly reduced.

Dr. Stuart Lipton, a neuroscientist at Scripps Laboratory, said, `We've done a number of different tests of memory, and the mice have all improved with drugs"The symptoms of Alzheimer's disease have not only stopped, but have actually returned to normal.", he explained.




Carnosan is used to promote hair growth with its anti-inflammatory and antioxidant properties. Some researchers also said that rosemary oil, which is rich in compounds, can stimulate the blood circulation of the scalp to youthfulize and strengthen hair follicles.

Prior research has found that carnosic acid can not only have a neuroprotective effect by protecting hippocampal neurons, but can also help the brain fight oxidative stress.

Dr. Lipton said "Carnosic acid may be effective in treating Alzheimer's disease as well as other inflammatory conditions such as diabetes, heart disease and Parkinson's disease."When combined with the current Alzheimer's treatment, we expect to have a greater therapeutic effect."




However, the results of this study are limited because they are experiments on mice.

In response, the researchers predicted that clinical trials on humans could proceed soon as the US Food and Drug Administration (FDA) classifies carnosic acid as a 'generally safe substance'.



This article was translated by Naver AI translator.